• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.

作者信息

Jia Guanghong, Aroor Annayya R, Hill Michael A, Sowers James R

机构信息

From the Diabetes and Cardiovascular Research Center (G.J., A.R.A., J.R.S.).

Research Service, Truman Memorial Veterans Hospital, Columbia, MO (G.H., A.R.A., J.R.S.).

出版信息

Hypertension. 2018 Sep;72(3):537-548. doi: 10.1161/HYPERTENSIONAHA.118.11065.

DOI:10.1161/HYPERTENSIONAHA.118.11065
PMID:29987104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202147/
Abstract
摘要

相似文献

1
Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.肾素-血管紧张素-醛固酮系统激活在促进心血管纤维化和僵硬中的作用。
Hypertension. 2018 Sep;72(3):537-548. doi: 10.1161/HYPERTENSIONAHA.118.11065.
2
Modulation of renin-angiotensin system and arterial stiffness: evidence from clinical trials.肾素-血管紧张素系统调节与动脉僵硬度：来自临床试验的证据。
Curr Hypertens Rev. 2014;10(1):37-40. doi: 10.2174/157340211001141111160311.
3
Cardiac consequences of aldosterone excess in human hypertension.人类高血压中醛固酮过量的心脏后果。
Am J Hypertens. 2006 Jan;19(1):10-2. doi: 10.1016/j.amjhyper.2005.08.011.
4
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).肾素-血管紧张素-醛固酮系统对血压和电解质平衡的作用及其在高血压、充血性心力衰竭以及相关心血管损伤（心肌梗死和中风）中的作用。
J Hum Hypertens. 1995 Jun;9(6):385-90.
5
[The renin-angiotensin system].[肾素-血管紧张素系统]
Urologe A. 2009 Aug;48(8):925-33; quiz 934-5. doi: 10.1007/s00120-009-2091-4.
6
Eplerenone: cardiovascular protection.依普利酮：心血管保护作用。
Circulation. 2003 May 20;107(19):2512-8. doi: 10.1161/01.CIR.0000071081.35693.9A.
7
Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.有效靶向心血管和肾脏疾病中的肾素-血管紧张素-醛固酮系统：联合使用血管紧张素II受体阻滞剂与血管紧张素转换酶抑制剂的理论依据
J Renin Angiotensin Aldosterone Syst. 2000 Sep;1(3):217-33. doi: 10.3317/jraas.2000.034.
8
Aldosterone in heart and kidney diseases.心脏和肾脏疾病中的醛固酮。
Hellenic J Cardiol. 2005 Nov-Dec;46(6):408-19.
9
Eplerenone, a new selective aldosterone blocker.依普利酮，一种新型选择性醛固酮受体拮抗剂。
Curr Pharm Des. 2003;9(13):1065-75. doi: 10.2174/1381612033455053.
10
Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.肾素-血管紧张素-醛固酮系统在血管重塑和炎症中的作用：一项临床综述
J Hypertens. 2006 Jun;24(6):983-91. doi: 10.1097/01.hjh.0000226182.60321.69.

引用本文的文献

1
Postoperative Adhesions: Current Research on Mechanisms, Therapeutics and Preventative Measures.术后粘连：关于机制、治疗方法及预防措施的当前研究
Biomed Mater Devices. 2025 Sep;3(2):897-937. doi: 10.1007/s44174-024-00236-7. Epub 2024 Sep 17.
2
Clinical and Biochemical Outcomes of Super-Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta-Analysis.原发性醛固酮增多症中超选择性肾上腺动脉栓塞术的临床和生化结果：一项系统评价和荟萃分析
J Clin Hypertens (Greenwich). 2025 Jul;27(7):e70088. doi: 10.1111/jch.70088.
3
The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice.

本文引用的文献

1
Targeting autophagy in obesity: from pathophysiology to management.靶向肥胖症的自噬作用：从病理生理学到管理。
Nat Rev Endocrinol. 2018 Jun;14(6):356-376. doi: 10.1038/s41574-018-0009-1.
2
Spironolactone is superior to hydrochlorothiazide for blood pressure control and arterial stiffness improvement: A prospective study.螺内酯在控制血压和改善动脉僵硬度方面优于氢氯噻嗪：一项前瞻性研究。
Medicine (Baltimore). 2018 Apr;97(16):e0500. doi: 10.1097/MD.0000000000010500.
3
Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
血管紧张素II 2型受体可减轻雌性小鼠与衰老相关的动脉僵硬度。
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H388-H394. doi: 10.1152/ajpheart.00328.2025. Epub 2025 Jul 7.
4
Vascular (dys)function in the failing heart.衰竭心脏中的血管（功能失调）功能
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01163-w.
5
Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies.阿霉素诱导的心脏重塑：机制与缓解策略。
Cardiovasc Drugs Ther. 2025 Feb 26. doi: 10.1007/s10557-025-07673-6.
6
A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy.肥胖药物治疗时代的间歇性禁食与心血管风险展望
Front Nutr. 2025 Jan 17;12:1524125. doi: 10.3389/fnut.2025.1524125. eCollection 2025.
7
The renin-angiotensin-aldosterone system and salt sensitivity of blood pressure offer new insights in obesity phenotypes.肾素-血管紧张素-醛固酮系统与血压的盐敏感性为肥胖表型提供了新的见解。
Obesity (Silver Spring). 2025 Feb;33(2):321-330. doi: 10.1002/oby.24218. Epub 2025 Jan 19.
8
Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential.射血分数保留的心力衰竭中的热量限制及其模拟物：机制与治疗潜力
Cardiovasc Diabetol. 2025 Jan 18;24(1):21. doi: 10.1186/s12933-024-02566-8.
9
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults.老年人心力射血分数保留的心力衰竭（HFpEF）的药物治疗
Drugs Aging. 2025 Feb;42(2):95-110. doi: 10.1007/s40266-024-01165-2. Epub 2025 Jan 18.
10
Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno-Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction.以腺相关病毒肾素构建的代谢综合征非酒精性脂肪性肝炎雄性小鼠作为射血分数保留的心力衰竭新模型。
J Am Heart Assoc. 2024 Dec 3;13(23):e035894. doi: 10.1161/JAHA.124.035894. Epub 2024 Nov 22.
药物抑制组织转谷氨酰胺酶的酶作用可减少压力超负荷后的心肌纤维化并减轻心肌细胞肥大。
J Mol Cell Cardiol. 2018 Apr;117:36-48. doi: 10.1016/j.yjmcc.2018.02.016. Epub 2018 Mar 2.
4
Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging.平滑肌细胞-盐皮质激素受体作为衰老导致心血管僵硬度的中介。
Hypertension. 2018 Apr;71(4):609-621. doi: 10.1161/HYPERTENSIONAHA.117.10437. Epub 2018 Feb 20.
5
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.糖尿病性心肌病：导致这一临床实体的机制更新。
Circ Res. 2018 Feb 16;122(4):624-638. doi: 10.1161/CIRCRESAHA.117.311586.
6
Vascular smooth muscle contraction in hypertension.高血压中的血管平滑肌收缩。
Cardiovasc Res. 2018 Mar 15;114(4):529-539. doi: 10.1093/cvr/cvy023.
7
Aldosterone, SGK1, and ion channels in the kidney.醛固酮、SGK1 和肾脏中的离子通道。
Clin Sci (Lond). 2018 Jan 19;132(2):173-183. doi: 10.1042/CS20171525. Print 2018 Jan 31.
8
The Role of MicroRNAs in Arterial Stiffness and Arterial Calcification. An Update and Review of the Literature.微小RNA在动脉僵硬度和动脉钙化中的作用。文献综述与更新
Front Genet. 2017 Dec 12;8:209. doi: 10.3389/fgene.2017.00209. eCollection 2017.
9
Arterial stiffness and peripheral vascular resistance in offspring of hypertensive parents: influence of sex and other confounders.高血压父母子女的动脉僵硬度和外周血管阻力：性别和其他混杂因素的影响。
J Hypertens. 2018 Apr;36(4):815-823. doi: 10.1097/HJH.0000000000001645.
10
Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-associated aortic remodeling.血管平滑肌细胞自噬缺失加剧血管紧张素Ⅱ相关性主动脉重构。
J Vasc Surg. 2018 Sep;68(3):859-871. doi: 10.1016/j.jvs.2017.08.086. Epub 2017 Dec 19.